Publications

Found 8 results
Filters: Author is D. Wu  [Clear All Filters]
2012
F. - X. Li, Tan, J. - Y., Yang, X. - X., Wu, Y. - S., Wu, D., and Li, M., Genetic variants on 17q21 are associated with asthma in a Han Chinese population, vol. 11, pp. 340-347, 2012.
Bisgaard H, Bonnelykke K, Sleiman PM, Brasholt M, et al. (2009). Chromosome 17q21 gene variants are associated with asthma and exacerbations but not atopy in early childhood. Am. J. Respir. Crit. Care Med. 179: 179-185. http://dx.doi.org/10.1164/rccm.200809-1436OC PMid:19029000 Bouzigon E, Corda E, Aschard H, Dizier MH, et al. (2008). Effect of 17q21 variants and smoking exposure in early-onset asthma. N. Engl. J. Med. 359: 1985-1994. http://dx.doi.org/10.1056/NEJMoa0806604 PMid:18923164 Eder W, Ege MJ and von Mutius E (2006). The asthma epidemic. N. Engl. J. Med. 355: 2226-2235. http://dx.doi.org/10.1056/NEJMra054308 PMid:17124020 Flory JH, Sleiman PM, Christie JD, Annaiah K, et al. (2009). 17q12-21 variants interact with smoke exposure as a risk factor for pediatric asthma but are equally associated with early-onset versus late-onset asthma in North Americans of European ancestry. J. Allergy Clin. Immunol. 124: 605-607. http://dx.doi.org/10.1016/j.jaci.2009.05.047 PMid:19660801 Galanter J, Choudhry S, Eng C, Nazario S, et al. (2008). ORMDL3 gene is associated with asthma in three ethnically diverse populations. Am. J. Respir. Crit. Care Med. 177: 1194-1200. http://dx.doi.org/10.1164/rccm.200711-1644OC PMid:18310477 PMCid:2408437 Halapi E, Gudbjartsson DF, Jonsdottir GM, Bjornsdottir US, et al. (2010). A sequence variant on 17q21 is associated with age at onset and severity of asthma. Eur. J. Hum. Genet. 18: 902-908. http://dx.doi.org/10.1038/ejhg.2010.38 PMid:20372189 PMCid:2987388 Hirota T, Harada M, Sakashita M, Doi S, et al. (2008). Genetic polymorphism regulating ORM1-like 3 (Saccharomyces cerevisiae) expression is associated with childhood atopic asthma in a Japanese population. J. Allergy Clin. Immunol. 121: 769-770. http://dx.doi.org/10.1016/j.jaci.2007.09.038 PMid:18155279 Hjelmqvist L, Tuson M, Marfany G, Herrero E, et al. (2002). ORMDL proteins are a conserved new family of endoplasmic reticulum membrane proteins. Genome Biol. 3: RESEARCH0027. Leung TF, Sy HY, Ng MC, Chan IH, et al. (2009). Asthma and atopy are associated with chromosome 17q21 markers in Chinese children. Allergy 64: 621-628. http://dx.doi.org/10.1111/j.1398-9995.2008.01873.x PMid:19175592 Li X, Yang XX, Hu NY, Sun JZ, et al. (2011). A risk-associated single nucleotide polymorphism of SMAD7 is common to colorectal, gastric, and lung cancers in a Han Chinese population. Mol. Biol. Rep. 38: 5093-5097. http://dx.doi.org/10.1007/s11033-010-0656-3 PMid:21221812 Madore AM, Tremblay K, Hudson TJ and Laprise C (2008). Replication of an association between 17q21 SNPs and asthma in a French-Canadian familial collection. Hum. Genet. 123: 93-95. http://dx.doi.org/10.1007/s00439-007-0444-x PMid:17992541 Moffatt MF, Kabesch M, Liang L, Dixon AL, et al. (2007). Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448: 470-473. http://dx.doi.org/10.1038/nature06014 PMid:17611496 Ober C and Hoffjan S (2006). Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun. 7: 95-100. http://dx.doi.org/10.1038/sj.gene.6364284 PMid:16395390 Sleiman PM, Annaiah K, Imielinski M, Bradfield JP, et al. (2008). ORMDL3 variants associated with asthma susceptibility in North Americans of European ancestry. J. Allergy Clin. Immunol. 122: 1225-1227. http://dx.doi.org/10.1016/j.jaci.2008.06.041 PMid:18760456 Tavendale R, MacGregor DF, Mukhopadhyay S and Palmer CN (2008). A polymorphism controlling ORMDL3 expression is associated with asthma that is poorly controlled by current medications. J. Allergy Clin. Immunol. 121: 860-863. http://dx.doi.org/10.1016/j.jaci.2008.01.015 PMid:18395550 Wjst M (2008). ORMDL3 - guilt by association? Clin. Exp. Allergy 38: 1579-1581. http://dx.doi.org/10.1111/j.1365-2222.2008.03086.x Wu H, Romieu I, Sienra-Monge JJ, Li H, et al. (2009). Genetic variation in ORM1-like 3 (ORMDL3) and gasdermin-like (GSDML) and childhood asthma. Allergy 64: 629-635. http://dx.doi.org/10.1111/j.1398-9995.2008.01912.x PMid:19133921 PMCid:2697826
2011
D. Wu, Wu, Y., Liu, J. L., Wang, B., and Zhang, X. D., Association between HLA-Cw*0602 polymorphism and psoriasis risk: a meta-analysis, vol. 10, pp. 3109-3120, 2011.
Asumalahti K, Laitinen T, Itkonen-Vatjus R, Lokki ML, et al. (2000). A candidate gene for psoriasis near HLA-C, HCR (Pg8), is highly polymorphic with a disease-associated susceptibility allele. Hum. Mol. Genet. 9: 1533-1542. http://dx.doi.org/10.1093/hmg/9.10.1533 PMid:10888604 Attia J, Thakkinstian A and D’Este C (2003). Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J. Clin. Epidemiol. 56: 297-303. http://dx.doi.org/10.1016/S0895-4356(03)00011-8 Brandrup F, Holm N, Grunnet N, Henningsen K, et al. (1982). Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution. Acta Derm. Venereol. 62: 229-236. PMid:6179364 Brazzelli V, Quaglini M, Martinetti M, Nolli G, et al. (2000). A peculiar sequence motif in the alpha-1-domain of the HLA-C molecule in psoriasis. Dermatology 200: 99-103. http://dx.doi.org/10.1159/000018338 PMid:10773694 Chandran V and Raychaudhuri SP (2010). Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J. Autoimmun. 34: J314-J321. http://dx.doi.org/10.1016/j.jaut.2009.12.001 PMid:20034760 Chang YT, Shiao YM, Chin PJ, Liu YL, et al. (2004). Genetic polymorphisms of the HCR gene and a genomic segment in close proximity to HLA-C are associated with patients with psoriasis in Taiwan. Br. J. Dermatol. 150: 1104-1111. http://dx.doi.org/10.1111/j.1365-2133.2004.05972.x PMid:15214895 Chang YT, Liu HN, Shiao YM, Lin MW, et al. (2005). A study of PSORS1C1 gene polymorphisms in Chinese patients with psoriasis. Br. J. Dermatol. 153: 90-96. http://dx.doi.org/10.1111/j.1365-2133.2005.06570.x PMid:16029332 Chang YT, Chou CT, Shiao YM, Lin MW, et al. (2006). Psoriasis vulgaris in Chinese individuals is associated with PSORS1C3 and CDSN genes. Br. J. Dermatol. 155: 663-669. http://dx.doi.org/10.1111/j.1365-2133.2006.07420.x PMid:16965413 Duffin KC, Chandran V, Gladman DD, Krueger GG, et al. (2008). Genetics of psoriasis and psoriatic arthritis: update and future direction. J. Rheumatol. 35: 1449-1453. PMid:18609743    PMCid:2724000 Fan X, Yang S, Sun LD, Liang YH, et al. (2007). Comparison of clinical features of HLA-Cw*0602-positive and -negative psoriasis patients in a Han Chinese population. Acta Derm. Venereol. 87: 335-340. http://dx.doi.org/10.2340/00015555-0253 PMid:17598037 Farber EM, Nall ML and Watson W (1974). Natural history of psoriasis in 61 twin pairs. Arch Dermatol. 109: 207-211. http://dx.doi.org/10.1001/archderm.1974.01630020023005 PMid:4814926 Fojtíková M, Stolfa J, Novota P, Cejkova P, et al. (2009). HLA-Cw*06 class I region rather than MICA is associated with psoriatic arthritis in Czech population. Rheumatol. Int. 29: 1293-1299. http://dx.doi.org/10.1007/s00296-009-0847-1 PMid:19184033 Gonzalez S, Martinez-Borra J, Torre-Alonso JC, Gonzalez-Roces S, et al. (1999). The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis Rheum. 42: 1010-1016. http://dx.doi.org/10.1002/1529-0131(199905)42:5<1010::AID-ANR21>3.0.CO;2-H Griffiths CE and Barker JN (2007). Pathogenesis and clinical features of psoriasis. Lancet 370: 263-271. http://dx.doi.org/10.1016/S0140-6736(07)61128-3 Gudjonsson JE, Karason A, Antonsdottir A, Runarsdottir EH, et al. (2003). Psoriasis patients who are homozygous for the HLA-Cw*0602 allele have a 2.5-fold increased risk of developing psoriasis compared with Cw6 heterozygotes. Br. J. Dermatol. 148: 233-235. http://dx.doi.org/10.1046/j.1365-2133.2003.05115.x PMid:12588373 Gudjonsson JE, Johnston A, Sigmundsdottir H and Valdimarsson H (2004). Immunopathogenic mechanisms in psoriasis. Clin. Exp. Immunol. 135: 1-8. http://dx.doi.org/10.1111/j.1365-2249.2004.02310.x PMid:14678257    PMCid:1808928 Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558. http://dx.doi.org/10.1002/sim.1186 PMid:12111919 Holm SJ, Sanchez F, Carlen LM, Mallbris L, et al. (2005a). HLA-Cw*0602 associates more strongly to psoriasis in the Swedish population than variants of the novel 6p21.3 gene PSORS1C3. Acta Derm. Venereol. 85: 2-8. http://dx.doi.org/10.1080/00015550410023527 Holm SJ, Sakuraba K, Mallbris L, Wolk K, et al. (2005b). Distinct HLA-C/KIR genotype profile associates with guttate psoriasis. J. Invest. Dermatol. 125: 721-730. http://dx.doi.org/10.1111/j.0022-202X.2005.23879.x PMid:16185272 Jobim M, Jobim LF, Salim PH, Cestari TF, et al. (2008). A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with Psoriasis vulgaris. Tissue Antigens 72: 392-396. http://dx.doi.org/10.1111/j.1399-0039.2008.01096.x PMid:18643961 Liu Y, Helms C, Liao W, Zaba LC, et al. (2008). A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 4: e1000041. http://dx.doi.org/10.1371/journal.pgen.1000041 PMid:18369459    PMCid:2274885 Lowes MA, Bowcock AM and Krueger JG (2007). Pathogenesis and therapy of psoriasis. Nature 445: 866-873. http://dx.doi.org/10.1038/nature05663 PMid:17314973 Luft FC (2005). Light shed on the common skin scourge, psoriasis. J. Mol. Med. 83: 933-934. http://dx.doi.org/10.1007/s00109-005-0724-7 PMid:16323032 Luszczek W, Kubicka W, Cislo M, Nockowski P, et al. (2003). Strong association of HLA-Cw6 allele with juvenile psoriasis in Polish patients. Immunol. Lett. 85: 59-64. http://dx.doi.org/10.1016/S0165-2478(02)00212-2 Mallbris L, Wolk K, Sanchez F and Stahle M (2009). HLA-Cw*0602 associates with a twofold higher prevalence of positive streptococcal throat swab at the onset of psoriasis: a case control study. BMC Dermatol. 9: 5. http://dx.doi.org/10.1186/1471-5945-9-5 PMid:19480679    PMCid:2696405 Martínez-Borra J, Gonzalez S, Santos-Juanes J, Sanchez del RJ, et al. (2003). Psoriasis vulgaris and psoriatic arthritis share a 100 kb susceptibility region telomeric to HLA-C. Rheumatology 42: 1089-1092. http://dx.doi.org/10.1093/rheumatology/keg304 PMid:12730526 Martínez-Borra J, Brautbar C, Gonzalez S, Enk CD, et al. (2005). The region of 150 kb telometic to HLA-C is associated with psoriasis in the Jewish population. J. Invest. Dermatol. 125: 928-932. PMid:16297191 Nair RP, Stuart PE, Nistor I, Hiremagalore R, et al. (2006). Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am. J. Hum. Genet. 78: 827-851. http://dx.doi.org/10.1086/503821 PMid:16642438 Naldi L and Mercuri SR (2010). Epidemiology of comorbidities in psoriasis. Dermatol. Ther. 23: 114-118. http://dx.doi.org/10.1111/j.1529-8019.2010.01304.x PMid:20415817 Nestle FO, Kaplan DH and Barker J (2009). Psoriasis. N. Engl. J. Med. 361: 496-509. http://dx.doi.org/10.1056/NEJMra0804595 PMid:19641206 Peters JL, Sutton AJ, Jones DR, Abrams KR, et al. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295: 676-680. http://dx.doi.org/10.1001/jama.295.6.676 PMid:16467236 Płoski R, Luszczek W, Kuśnierczyk P, Nockowski P, et al. (2006). A role for KIR gene variants other than KIR2DS1 in conferring susceptibility to psoriasis. Hum. Immunol. 67: 521-526. http://dx.doi.org/10.1016/j.humimm.2006.04.001 PMid:16829306 Rani R, Narayan R, Fernandez-Vina MA and Stastny P (1998). Role of HLA-B and C alleles in development of psoriasis in patients from North India. Tissue Antigens 51: 618-622. http://dx.doi.org/10.1111/j.1399-0039.1998.tb03004.x PMid:9694354 Raychaudhuri SP and Gross J (2000a). A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr. Dermatol. 17: 174-178. http://dx.doi.org/10.1046/j.1525-1470.2000.01746.x PMid:10886746 Raychaudhuri SP and Gross J (2000b). Psoriasis risk factors: role of lifestyle practices. Cutis 66: 348-352. PMid:11107520 Raychaudhuri SP and Farber EM (2001). The prevalence of psoriasis in the world. J. Eur. Acad. Dermatol. Venereol. 15: 16-17. http://dx.doi.org/10.1046/j.1468-3083.2001.00192.x PMid:11451313 Reveille JD and Williams FM (2006). Infection and musculoskeletal conditions: Rheumatologic complications of HIV infection. Best Pract. Res. Clin. Rheumatol. 20: 1159-1179. http://dx.doi.org/10.1016/j.berh.2006.08.015 Sánchez F, Holm SJ, Mallbris L, O’Brien KP, et al. (2004). STG does not associate with psoriasis in the Swedish population. Exp. Dermatol. 13: 413-418. http://dx.doi.org/10.1111/j.0906-6705.2004.00170.x PMid:15217361 Schon MP and Boehncke WH (2005). Psoriasis. N. Engl. J. Med. 352: 1899-1912. http://dx.doi.org/10.1056/NEJMra041320 PMid:15872205 Szczerkowska-Dobosz A (2005). Human leukocyte antigens as psoriasis inheritance and susceptibility markers. Arch. Immunol. Ther. Exp. 53: 428-433. Valdimarsson H (2007). The genetic basis of psoriasis. Clin. Dermatol. 25: 563-567. http://dx.doi.org/10.1016/j.clindermatol.2007.08.010 PMid:18021893 Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, et al. (2007). Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 18: 805-835. http://dx.doi.org/10.1097/EDE.0b013e3181577511 PMid:18049195 Watson W, Cann HM, Farber EM and Nall ML (1972). The genetics of psoriasis. Arch. Dermatol. 105: 197-207. http://dx.doi.org/10.1001/archderm.1972.01620050011002 PMid:5060862 Zhang XJ, Zhang AP, Yang S, Gao M, et al. (2003). Association of HLA class I alleles with Psoriasis vulgaris in southeastern Chinese Hans. J. Dermatol. Sci. 33: 1-6. http://dx.doi.org/10.1016/S0923-1811(03)00157-9 Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 28: 123-137. http://dx.doi.org/10.1002/gepi.20048 PMid:15593093